AVXL Other Income/Expenses (Net)
Anavex Life Sciences Corp · Other Income/Expenses (Net)
AVXL Other Income/Expenses (Net)
Latest reported$6.61Mperiod ending
AVXL TTM Other Income/Expenses (Net) ($142.55K → $6.61M)
TTM Other Income/Expenses (Net)
High-resolution chart · PNG
AVXL other income/expenses (net) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Other Income/Expenses (Net) (USD) |
|---|---|
| 6,607,000 | |
| 4,471,000 | |
| 4,669,000 | |
| 5,031,000 | |
| 6,606,000 | |
| 7,779,000 | |
| 8,540,000 | |
| 9,815,000 | |
| 9,665,208 | |
| 9,568,208 | |
| 8,623,208 | |
| 8,234,208 | |
| 6,995,849 | |
| 4,883,649 | |
| 4,862,385 | |
| 3,366,388 | |
| 2,838,398 | |
| 3,872,832 | |
| 3,576,628 | |
| 4,306,016 | |
| 5,181,425 | |
| 5,591,865 | |
| 5,237,881 | |
| 4,680,538 | |
| 5,527,250 | |
| 4,472,181 | |
| 4,877,287 | |
| 4,322,214 | |
| 1,981,121 | |
| 3,105,837 | |
| 2,249,493 | |
| 1,803,873 | |
| 1,779,150 | |
| 120,778 | |
| 2,163,239 | |
| 2,138,621 | |
| 2,156,707 | |
| 2,132,300 | |
| 202,017 | |
| 169,672 | |
| -1,270,150 | |
| -4,008,976 | |
| -4,997,984 | |
| -4,999,416 | |
| -12,669,517 | |
| -9,952,490 | |
| -9,083,663 | |
| -8,399,378 | |
| -862,292 | |
| -877,977 | |
| -859,273 | |
| -1,565,658 | |
| 604,275 | |
| -3,216,056 | |
| -3,352,609 | |
| -3,300,508 | |
| -2,721,280 | |
| 1,180,520 | |
| 1,269,653 | |
| 738,086 | |
| 1,475,512 | |
| 2,722,849 | |
| 2,552,647 | |
| 3,482,634 | |
| 3,319,784 | |
| 3,274,478 | |
| 4,242,016 | |
| 4,736,358 | |
| 5,278,712 | |
| 5,358,634 | |
| 5,259,438 | |
| 5,341,739 | |
| 4,139,008 | |
| 3,057,097 | |
| 2,554,149 | |
| 1,577,464 | |
| 442,536 | |
| 192,647 | |
| 28,524 | |
| 25,592 | |
| 61,492 | |
| 101,510 | |
| 142,548 | |
| 137,239 |